Scott Lipman, MBA
Scott Lipman, MBA, serves as chief of staff. Prior to this role, he was an integral part of the Business Development and Strategy, and Investor Relations teams at Turning Point, most recently serving as senior director, Corporate and Business Development.
Prior to Turning Point Therapeutics, Mr. Lipman worked in Healthcare Investment Banking at Goldman Sachs, where he advised management teams on a range of strategic financial matters, executed financings as well as M&A transactions. He also has worked as a management consultant at ZS Associates, advising biopharma clients on a range of strategic issues, including commercial planning, lifecycle planning, and business development and licensing.
Mr. Lipman received his B.S. in Chemical Engineering from the University of California, Los Angeles and his M.B.A. from the Kellogg School of Management at Northwestern University.